Aim: n-Propanol extracts from fresh, boiled, and fermented seeds were studied to evaluate their neuroprotective effects in a Parkinson's disease (PD) rat model, based on the total number of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc).

Materials and Methods: Rats were induced with paraquat dichloride at a dosage of 7 mg/kg BW intraperitoneally twice a week and at the same time supplemented with extract at a dosage of 70 mg/kg BW orally every day for 3 weeks. On the 24th day, all rats were perfused and fixed with 4% paraformaldehyde. The left part of the SNpc was processed for immunohistochemical staining with tyrosine hydroxylase (TH)-antibody. The total number of DA neurons in SNpc was evaluated with a stereological method.

Results: TH-immunoreactive cells found in the SNpc were identified as DA neurons. The average total number of DA neurons in the SNpc increased significantly in the PD rat model that was given an n-propanol extract of boiled and fermented seeds compared with a control PD rat model. Surprisingly, there was no significant difference in the average total number of DA neurons in SNpc between the PD rat model that was given n-propanol extract of fresh seeds and the control PD rat model.

Conclusion: n-Propanol extract of boiled and fermented seeds could produce a higher neuroprotective effect against DA neuron than fresh seeds in a PD rat model.

Keywords: animal model, Mucuna pruriens, neuroprotective, paraquat dichloride, Parkinson's disease.

1. WHO. (1998) The World Health Report 1998-Life in the 21st Century: A Vision for All. World Health Organization, Geneva.

2. WHO. (2006) Neurological Disorders: Public Health Challenges. World Health Organization, Geneva.

3. Mackenzie, I.R.A. (2005) Neuropathology of atypical parkinsonian disorders. In: Litvan, I. (Eds). Atypical Parkinsonian Disorders. Current Clinical Neurology. Humana Press, Philadelphia, PA. [Crossref]

4. Uversky, V.N. (2004) Neurotoxicant-induced animal models of Parkinson's disease: Understanding the role of rotenone, maneb, and paraquat in neurodegeneration. Cell Tissue Res., 318: 225-241. [Crossref] [PubMed]

5. Logroscino, G. (2005) The Role of early life environmental risk factors in Parkinson disease: What is the evidence? Environ. Health Perspect., 113(9): 1234-1238. [Crossref] [PubMed] [PMC]

6. Fearnley, J.M. and Lees, A.J. (1991) Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain., 114: 2283-2301. [Crossref] [PubMed]

7. Kalia, L.V. and Lang, A.E. (2015) Parkinson's disease. Lancet., 386: 896-912. [Crossref]

8. Stansley, B.J. and Yamamoto, B.K. (2015) L-dopa and brain serotonin system dysfunction. Toxics., 3(1): 75-88. [Crossref] [PubMed] [PMC]

9. Giessen, R.V.D., Olanow, W., Lees, A. and Wagner, H. (2006) Pharmaceutical Compositions and Uses Comprising Mucuna pruriens Seed Powder and Extracts thereof in the Treatment of Neurological Disease. United States Patent, US 0165822 A1.

10. Manyam, B.V., Dhanasekaran, M. and Hare, T.A. (2004) Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Phytother. Res., 18(9): 706-712. [Crossref] [PubMed]

11. Sabesan, M. and Subramanian, A. (2010) Neuroprotective effect of nanomucuna (Mucuna Pruriens Gold Nanoparticle) on MPTP induced parkinsonism in male mice. J Neurochem., 115: 56-66.

12. Madhyastha, S., Chauhan, R., Rao, G.M. and Hema, U. (2011) Neuroprotective effects of Mucuna pruriens against stress-induced oxidative damage. J. Physiol. Biomed. Sci., 24(2): 28-33.

13. Yadav, S.K., Prakash, J., Chouhan, S., Westfall, S., Verma, M., Singh, T.D. and Singh, S.P. (2014) Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model. Neurochem. Int., 65: 1-13. [Crossref] [PubMed]

14. Yadav, S.K., Rai, S.N. and Singh, S.P. (2016) Mucuna pruriens shows neuroprotective effect by inhibiting apoptotic pathways of dopaminergic neurons in the paraquat mouse model of parkinsonism. Eur. J. Pharm. Med. Res., 3(8): 441-451.

15. Paxinos, G. and Watson, C. (2007) The Rat Brain: In Stereotaxic Coordinates. 6th ed. Elsevier, China.

16. Boyce, R.W., Dorph-Petersen, A.K., Lyck, L. and Gundersen, H.J.G. (2010) Design-based stereology: Introduction to basic concepts and practical approaches for estimation of cell number. Toxicol. Pathol., 38(7): 1011-1025. [Crossref] [PubMed]

17. Nair-Roberts, R.G., Chatelain-Badie, S.D., Benson, E., White-Cooper, H., Bolam, J.P. and Ungless, M.A. (2008) Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience., 152(4): 1024-1031. [Crossref] [PubMed] [PMC]

18. Somayajulu-Nitu, M., Sandhu, J.K., Cohen, J., Sikorska, M., Sridhar, T.S., Matei, A., Borowy-Borowski, H. and Pandey, S. (2009) Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10. BMC Neurosci., 10: 88. [Crossref] [PubMed] [PMC]

19. Pangestiningsih, T.W., Wendo, W.D., Selan, Y.N., Amalo, F.A., Ndaong, N.A. and Lenda, V. (2014) Histological features of catecholaminergic neuron in substantia nigra induced by paraquat dichloride (1,1-dimethyl-4,4 bipyridinium) in Wistar rat as a model of Parkinson disease. IJ Biotech., 19(1): 91-98.

20. Smeets, W.J.A.J. and Rainer, A. (1994) Phylogeny Development of Catecholamine System in the CNS of Vertebrate. Cambridge Univ Press, Cambridge.

21. Kato, K., Yamaguchi-Yamada, M. and Yamamoto, Y. (2010) Short-term hypoxia increases tyrosine hydroxylase immunoreactivity in rat carotid body. J. Histochem. Cytochem., 58(9): 839-846. [Crossref] [PubMed] [PMC]

22. Daubner, S.C., Le, T. and Wang, S. (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem. Biophys., 508(1): 1-12. [Crossref] [PubMed] [PMC]

23. Nagatsu, T. and Nagatsu, I. (2016) Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): Historical overview and future prospects. J. Neural. Transm., 123(11): 1255-1278. [Crossref] [PubMed]

24. Pengestiningsih, T.W., Susmiati, T. and Wijayanto, H. (2017) L-3,4-dihydroxyphenylalanine content as a neuroprotective material on fresh, cooked and fermented of koro benguk (Mucuna pruriens) beans. J. Vet., 18(1): 116-120.

25. Fahim, M.A., Nemmar, A., Shehab, S., Dhanasekaran, S., Yasin, J., Shafiullah, M. and Hasan, M. (2016) Vitamin E mitigates the decremental effect of paraquat on substantia nigra neurons. FASEB J., 30(1): 742.1.

26. Brooks, A.I., Chadwick, C.A., Gelbard, H.A., Cory-Slechta, D.A. and Federoff, H.J. (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res., 823(1-2): 1-10. [Crossref]

27. McCormack, A.L., Thiruchelvam, M., Manning-Bog, A.B., Thiffault, C., Langston, J.W., Cory-Slechta, D.A. and Monte, D.A. (2002) Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis., 10(2): 119-127. [Crossref] [PubMed]

28. Blesa, J., Trigo-Damas, I., Quiroga-Varela, A. and Lopez-Gonzalez del Rey, N. (2016) Animal models of Parkinson's disease. In: Dorszewska, J. and Kozubski, W., (Ed). Challenges in Parkinson's Disease. InTechOpen, UK, p. 195-216. [Crossref]

29. Ray, S., Sengupta, A. and Ray. A. (2007) Effects of paraquat on antioxidant system in rats. Indian J. Exp. Biol., 45(5): 432-438. [PubMed]

30. Berry, C., La V.C. and Nicotera, P. (2010) Paraquat and Parkinson's disease. Cell Death Differ., 17(7): 1115-1125. [Crossref] [PubMed]

31. Chance, B., Sies, H. and Boveris, A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev., 59(3): 527-605. [Crossref] [PubMed]

32. Repetto, M., Semprine, J. and Boveris, A. (2012) Lipid peroxidation: Chemical mechanism, biological implications and analytical determination. In: Catala, A., (Ed.). Lipid Peroxidation. InTechOpen, UK, p. 3-30. [Crossref]

33. Lieu, C.A., Venkiteswaran, K., Gilmour, T.P., Rao, A.N., Petticoffer, A.C., Gilbert, E.V., Deogaonkar, M., Manyam, B.V. and Subramanian, T. (2012) The antiparkinsonian and antidyskinetic mechanisms of Mucuna pruriens in the MPTP-treated nonhuman primate. Evid. Based Complement Alternat. Med., 2012(840247): 1-10.

---